About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72834 record(s)
Req # A-2021-001964
All documents submitted by BioNTech Manufacturing Company GmbH or Pfizer as part of the regulatory review that resulted in the Regulatory Decision Summary (Interim Order) dated December 9, 2020 for the Comirnaty Vaccine. The full regulatory review…Organization: Health Canada
August 2024
Req # A-2022-000244
Any communication around (proposed) amendments to the International Health Regulations (https://www.who.int/health-topics/international-health-regulations#tab=tab_1), since June 1, 2021.Organization: Health Canada
August 2024
Req # A-2022-000443
All memos, briefing notes, emails and reports between the Health Ministers office and the Canadian Cancer Society from January 1, 2020 to July 1, 2022 about the COVID-19 pandemic and cancer.Organization: Health Canada
August 2024
Req # A-2022-001297
All documents relating to the applications for the following authorization reference numbers. Authorization Reference Number 327866, issued on October 20, 2021; Authorization Reference Number 318801, issued on May 5, 2021; Amendment Reference Number…Organization: Health Canada
August 2024
Req # A-2022-001596
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the medical devices establishment licence inspection of the Ferring facility on Yorkland Road,…Organization: Health Canada
August 2024
Req # A-2022-001597
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the medical device establishment licence inspection of the Ferring facility on Yorkland Road,…Organization: Health Canada
August 2024
Req # A-2023-000307
All correspondence between Health Canada employees Pierre Sabourin or David Boudreau and BTNX, Inc., between April 1, 2020 and November 30, 2022.Organization: Health Canada
August 2024
Req # A-2023-000733
The initial cover letter and any other document indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-08-17 for the medicinal…Organization: Health Canada
August 2024
Req # A-2023-000897
The application by Benoit Labre House to operate a supervised consumption site, along with any subsequent correspondence, complementary document, appendix, and the documents analyzing the application.Organization: Health Canada
August 2024
Req # A-2023-001138
With respect SUMMARY MONTHLY SAFETY REPORT #7. The date when this report was received; the date when the review was completed and by whom including expertise/specialty; findings including: newly identified signals, both validated and invalidated, as…Organization: Health Canada
August 2024